๐Ÿ•ต๏ธ Adverum Biotechnologies, Inc. ($ADVM)

SEC insider & ownership activity, last 12 months ยท CIK 1501756 ยท every row links its SEC filing

Over the last 12 months insiders sold $4.6M against $765K of open-market buying. Leonard Braden Michael sold $4.6M (Dec). One red-flag 8-K in the window: Delisting notice (3.01), Dec 9, 2025.

Aug 2025: net +$0 Oct 2025: net +$0 Oct 2025: net +$0 Dec 2025: net -$3.8M Dec 2025: net -$3.8M Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 May 2026: net +$0 May 2026: net +$0 Jul 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

2 buyers, $765K (3 lots) ยท 1 seller, $4.6M (4 lots)

InsiderBuysBoughtSellsSoldLast
Leonard Braden Michael0โ€“ 4$4.6MDec 4, 2025
Fischer Laurent2$554K 0โ€“Dec 8, 2025
Soparkar Peter1$211K 0โ€“Dec 5, 2025

5%+ holders

HolderStakeClassScheduleEvent
TCG Crossover GP II, LLC 8.9% 13GMay 15, 2025 filing โ†—
TCG Crossover Fund II, L.P. 8.9% 13GMay 15, 2025 filing โ†—
Chen Yu 8.9% 13GMay 15, 2025 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Acquisition or disposition (2.01)Dec 9, 2025 filing โ†—
Delisting notice (3.01)Dec 9, 2025 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Dec 9, 2025 filing โ†—
Change of control (5.01)Dec 9, 2025 filing โ†—
Officer/director changes (5.02)Dec 9, 2025 filing โ†—
Charter/bylaw changes (5.03)Dec 9, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 9, 2025 filing โ†—
Reg FD disclosure (7.01)Dec 4, 2025 filing โ†—
Other events (8.01)Dec 4, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 4, 2025 filing โ†—
Agreement terminated (1.02)Nov 19, 2025 filing โ†—
New financial obligation (2.03)Nov 19, 2025 filing โ†—
Other events (8.01)Nov 19, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 19, 2025 filing โ†—
Material agreement (1.01)Oct 24, 2025 filing โ†—
New financial obligation (2.03)Oct 24, 2025 filing โ†—
Reg FD disclosure (7.01)Oct 24, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 24, 2025 filing โ†—
Reg FD disclosure (7.01)Sep 22, 2025 filing โ†—
Other events (8.01)Sep 22, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 22, 2025 filing โ†—
Earnings (2.02)Aug 12, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 12, 2025 filing โ†—